Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
C03DA04 EPLERENONUM COMPR. FILM. 25 mg

INSPRA 25 mg 25 mg PFIZER EUROPE MA EEIG

C03DA04 EPLERENONUM COMPR. FILM. 50 mg

INSPRA 50 mg 50 mg PFIZER EUROPE MA EEIG

________________________________________________________________________________
______________________________________________________________________________

| 188 |C04AE02| NICERGOLINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C04AE02 NICERGOLINUM COMPR. FILM. 10 mg

NICERGOLINA LPH 10 mg 10 mg LABORMED PHARMA SA
C04AE02 NICERGOLINUM DRAJ. 10 mg

NICERIUM(R) 10 10 mg HEXAL AG

SINERGOLIN 10 10 mg SINTOFARM SA
C04AE02 NICERGOLINUM CAPS. ELIB. MODIF. 15 mg

NICERIUM(R) 15 15 mg HEXAL AG

C04AE02 NICERGOLINUM CAPS. ELIB. MODIF. 30 mg

NICERIUM(R) 30 UNO 30 mg HEXAL AG

C04AE02 NICERGOLINUM COMPR. FILM. 30 mg

NICERGOLINA LPH 30 mg 30 mg LABORMED PHARMA SA

SERMION 30 mg PFIZER EUROPE MA EEIG
C04AE02 NICERGOLINUM DRAJ. 30 mg

SINERGOLIN 30 30 mg SINTOFARM SA

C04AE02 NICERGOLINUM COMPR. FILM. 5 mg

NICERGOLINA LPH 5 mg 5 mg LABORMED PHARMA SA

________________________________________________________________________________
______________________________________________________________________________

| 189 |C04AX07| VINCAMINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C04AX07 VINCAMINUM DRAJ. 10 mg

VINCAMINA 10 mg BIOFARM SA
C04AX07 VINCAMINUM COMPR. 20 mg

VINCAMIL 20 mg FARMACEUTICI ECOBI S.A.S.

C04AX07 VINCAMINUM CAPS. ELIB. PREL. 30 mg

OXYBRAL SR 30 mg 30 mg GLAXO SMITHKLINE (GSK) SRL

________________________________________________________________________________
______________________________________________________________________________

| 190 |C04AXN1| GINKGO BILOBA** | Protocol: C001I |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C04AXN1 GINKGO BILOBA COMPR. FILM. 120 mg

GINGIUM 120 m 120 mg HEXAL AG
C04AXN1 GINKGO BILOBA COMPR. FILM. 40 mg

GINGIUM 40 mg 40 mg HEXAL AG

TEBOKAN 40 mg DR. WILLMAR SCHWABE GMBH &

CO KG
C04AXN1 GINKGO BILOBA CAPS. 80 mg

BILOBIL FORTE 80 mg KRKA D.D. NOVO MESTO
C04AXN1 GINKGO BILOBA COMPR. FILM. 80 mg

GINGIUM 80 mg 80 mg HEXAL AG

________________________________________________________________________________
______________________________________________________________________________

| 191 |C05CA53| DIOSMINUM (COMBINATII)** | Protocol: B016I |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C05CA53 DIOSMINUM COMPR. FILM. 500 mg

(COMBINATII)

DETRALEX(R) 500 mg LES LAB. SERVIER IND.

________________________________________________________________________________
______________________________________________________________________________

| 192 |C07AB12| NEBIVOLOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C07AB12 NEBIVOLOLUM COMPR. 5 mg

NEBILET(R) 5 mg BERLIN CHEMIE AG MENARINI

GROUP

________________________________________________________________________________
______________________________________________________________________________

| 193 |C07BB07| COMBINATII (BISOPROLOLUM + | |

| | | HYDROCHLOROTHIAZIDUM) | |

|_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C07BB07 COMBINATII COMPR. FILM.

(BISOPROLOLUM +

HYDROCHLOROTHIAZIDUM)

LODOZ 10 mg MERCK KGAA

LODOZ 2,5 mg MERCK KGAA

LODOZ 5 mg MERCK KGAA

________________________________________________________________________________

______________________________________________________________________________

| 194 |C07EBN1| COMBINATII (METOPROLOLUM + FELODIPINUM) | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C07EBN1 COMBINATII COMPR. ELIB. PREL. 50 mg + 5 mg

(METOPROLOLUM +

FELODIPINUM)

LOGIMAX(R) 50 mg + 5 mg ASTRAZENECA AB

________________________________________________________________________________

______________________________________________________________________________

| 195 |C08CA09| LACIDIPINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C08CA09 LACIDIPINUM COMPR. FILM. 4 mg

LACIPIL 4 mg 4 mg GLAXO OPERATIONS UK LTD.

________________________________________________________________________________

______________________________________________________________________________

| 196 |C08CA13| LERCANIDIPINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

C08CA13 LERCANIDIPINUM COMPR. FILM. 10 mg

LERIDIP 10 mg BERLIN CHEMIE AG MENARINI

GROUP
C08CA13 LERCANIDIPINUM COMPR. FILM. 20 mg

LERIDIP 20 20 mg BERLIN CHEMIE AG MENARINI

GROUP

________________________________________________________________________________
______________________________________________________________________________

| 197 |C09AA04| PERINDOPRILUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________
Utilizarea inhibitorilor enzimelor de conversie a angiotensinei în timpul sarcinii este contraindicată deoarece medicamentele din această categorie au fost asociate cu moartea fătului in utero.